AF
CRMD icon

Allworth Financial’s CorMedix CRMD Stock Holding History

Allworth Financial’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.4K Buy
11,267
+127
+1% +$1K ﹤0.01% 2031
2026
Q1 		$75.6K Sell
11,140
-58,565
-84% -$433K ﹤0.01% 2035
2025
Q4 		$811K Buy
69,705
+8,766
+14% +$96.9K ﹤0.01% 754
2025
Q3 		$709K Buy
60,939
+53,273
+695% +$644K ﹤0.01% 762
2025
Q2 		$94.4K Buy
7,666
+7,526
+5,376% +$83.1K ﹤0.01% 1573
2025
Q1 		$1.28K Hold
140
– – ﹤0.01% 3379
2024
Q4 		$1.72K Hold
140
– – ﹤0.01% 3205
2024
Q3 		$1.13K Hold
140
– – ﹤0.01% 3177
2024
Q2 		$651 Hold
140
– – ﹤0.01% 3298
2024
Q1 		$594 Hold
140
– – ﹤0.01% 3239
2023
Q4 		$527 Buy
+140
New +$482 ﹤0.01% 3120

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Allworth Financial's CRMD Position: Q2 2026 in Review

Allworth Financial increased its CorMedix (CRMD) stake by 1.1% in Q2 2026, buying an estimated $1K and bringing the position to 11,267 shares worth $88.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2031.

Allworth Financial first reported a position in CRMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $811K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Allworth Financial held 11,267 shares of CorMedix worth $88.4K as of Q2 2026.
  • Allworth Financial bought 127 CorMedix shares in Q2 2026, an estimated $1K.
  • CorMedix made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2031 holding.
  • Allworth Financial first reported a position in CorMedix in Q4 2023 and has held it in 11 quarters since.
  • Allworth Financial's CorMedix position peaked at $811K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.